Trace Neuroscience: Funding, Investors & Team (Oct 2026)
Launched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases. With an initial focus on ALS, the company is developing novel therapies to restore UNC13A protein function to re-establish healthy communication between nerves and muscle cells.
Trace Neuroscience has raised $101M across 1 funding round on record, the most recent a Series A of $101M announced in Nov 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Trace Neuroscience Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Trace Neuroscience Funding Rounds
Trace Neuroscience Founders and Leadership Team
No contact details are on record for this team yet.
Trace Neuroscience Funding Compared to Other Biotechnology Startups
Trace Neuroscience's latest round of $101M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Trace Neuroscience in Biotechnology and South San Francisco
Companies Similar to Trace Neuroscience
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Trace Neuroscience Funding FAQs
What does Trace Neuroscience do?
Launched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases. With an initial focus on ALS, the company is developing novel therapies to restore UNC13A protein function to re-establish healthy communication between nerves and muscle cells.
How much funding has Trace Neuroscience raised?
Trace Neuroscience has raised $101M across 1 round on record. The most recent is a Series A of $101M announced in Nov 2024.
When did Trace Neuroscience last raise funding?
Trace Neuroscience's most recent funding round on record is a Series A of $101M, announced in Nov 2024.
Who founded Trace Neuroscience?
FundedIQ lists Eric Green (Founder) at Trace Neuroscience.
Where is Trace Neuroscience headquartered?
Trace Neuroscience is based in South San Francisco, California, United States.
How many employees does Trace Neuroscience have?
Trace Neuroscience is in the 11-50 employee band.
How does Trace Neuroscience's funding compare to other Biotechnology startups?
Trace Neuroscience's latest round of $101M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Trace Neuroscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Trace Neuroscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.